
Sponsor
Beta Innov
49 Rue Rouelle, 75015 Paris, France
About the sponsor
Beta Innov is involved in clinical research focused on glioblastoma, with interest in advanced treatment approaches for aggressive brain tumours and related central nervous system malignancies.
- Glioblastoma
- Brain tumour therapy
- Central nervous system oncology
The sponsor’s research activity is centred on therapeutic development in a high-unmet-need area of oncology, with emphasis on disease-specific interventions for malignant glioma.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.
